<VariationArchive VariationID="449407" VariationName="NM_000158.4(GBE1):c.1239del (p.Asp413fs)" VariationType="Deletion" Accession="VCV000449407" Version="18" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-23" DateCreated="2017-12-19" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="443517" VariationID="449407">
      <GeneList>
        <Gene Symbol="GBE1" FullName="1,4-alpha-glucan branching enzyme 1" GeneID="2632" HGNC_ID="HGNC:4180" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p12.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="81489703" stop="81761645" display_start="81489703" display_stop="81761645" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="81538849" stop="81810949" display_start="81538849" display_stop="81810949" Strand="-" />
          </Location>
          <OMIM>607839</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000158.4(GBE1):c.1239del (p.Asp413fs)</Name>
      <CanonicalSPDI>NC_000003.12:81586187:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p12.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="81586188" stop="81586188" display_start="81586188" display_stop="81586188" variantLength="1" positionVCF="81586187" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="81635339" stop="81635339" display_start="81635339" display_stop="81635339" variantLength="1" positionVCF="81635338" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_000158.4(GBE1):c.1239del</Name>
        <Name>p.Asp413fs</Name>
      </OtherNameList>
      <ProteinChange>D413fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.81635339del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.81635339del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.81586188del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.81586188del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011810.1" sequenceAccession="NG_011810" sequenceVersion="1" change="g.180613del">
            <Expression>NG_011810.1:g.180613del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.4" sequenceAccession="NM_000158" sequenceVersion="4" change="c.1239del" MANESelect="true">
            <Expression>NM_000158.4:c.1239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000149.4" sequenceAccession="NP_000149" sequenceVersion="4" change="p.Asp413fs">
            <Expression>NP_000149.4:p.Asp413fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.3" sequenceAccession="NM_000158" sequenceVersion="3" change="c.1239del">
            <Expression>NM_000158.3:c.1239del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000158.4" sequenceAccession="NM_000158" sequenceVersion="4" change="c.1239delT" MANESelect="true">
            <Expression>NM_000158.4:c.1239delT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2499726" DB="ClinGen" />
        <XRef Type="rs" ID="758504480" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00003" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000158.4(GBE1):c.1239del (p.Asp413fs) AND not provided" Accession="RCV000519597" Version="9">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-10-06" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000158.4(GBE1):c.1239del (p.Asp413fs) AND multiple conditions" Accession="RCV001048981" Version="4">
        <ClassifiedConditionList TraitSetID="39830">
          <ClassifiedCondition DB="MedGen" ID="C1856301">Glycogen storage disease IV, classic hepatic</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0017923">Glycogen storage disease, type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000158.4(GBE1):c.1239del (p.Asp413fs) AND Glycogen storage disease, type IV" Accession="RCV001275861" Version="8">
        <ClassifiedConditionList TraitSetID="6269">
          <ClassifiedCondition DB="MedGen" ID="C0017923">Glycogen storage disease, type IV</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-18" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-18" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2017-12-19" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15019703</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15452297</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20058079</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28973083</ID>
        </Citation>
        <DescriptionHistory Dated="2022-02-12">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="39830" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5200" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylopectinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen branching enzyme deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cirrhosis, familial, with deposition of abnormal glycogen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to glycogen branching enzyme deficiency</ElementValue>
                <XRef ID="MONDO:0009292" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type IV</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+4/3124" DB="Genetic Alliance" />
                <XRef ID="11179002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD4</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2520" />
                <XRef ID="2520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families. The fatal perinatal neuromuscular subtype presents in utero with fetal akinesia deformation sequence, including decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period. The congenital neuromuscular subtype presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy. Infants with the classic (progressive) hepatic subtype may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years. Children with the non-progressive hepatic subtype tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement. The childhood neuromuscular subtype is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</Attribute>
                <XRef ID="NBK115333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23285490</ID>
                <ID Source="BookShelf">NBK115333</ID>
              </Citation>
              <XRef ID="367" DB="Orphanet" />
              <XRef ID="C0017923" DB="MedGen" />
              <XRef ID="MONDO:0009292" DB="MONDO" />
              <XRef Type="MIM" ID="232500" DB="OMIM" />
            </Trait>
            <Trait ID="9280" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD IV, CLASSIC HEPATIC</ElementValue>
                <XRef ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IV, classic hepatic</ElementValue>
              </Name>
              <XRef ID="C1856301" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6269" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5200" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GSD 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Andersen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Brancher deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amylopectinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen branching enzyme deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cirrhosis, familial, with deposition of abnormal glycogen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease due to glycogen branching enzyme deficiency</ElementValue>
                <XRef ID="MONDO:0009292" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GBE1 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD IV</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type IV</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+4/3124" DB="Genetic Alliance" />
                <XRef ID="11179002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GSD4</ElementValue>
                <XRef Type="MIM" ID="232500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2520" />
                <XRef ID="2520" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The clinical manifestations of glycogen storage disease type IV (GSD IV) discussed in this entry span a continuum of different subtypes with variable ages of onset, severity, and clinical features. Clinical findings vary extensively both within and between families. The fatal perinatal neuromuscular subtype presents in utero with fetal akinesia deformation sequence, including decreased fetal movements, polyhydramnios, and fetal hydrops. Death usually occurs in the neonatal period. The congenital neuromuscular subtype presents in the newborn period with profound hypotonia, respiratory distress, and dilated cardiomyopathy. Death usually occurs in early infancy. Infants with the classic (progressive) hepatic subtype may appear normal at birth, but rapidly develop failure to thrive; hepatomegaly, liver dysfunction, and progressive liver cirrhosis; hypotonia; and cardiomyopathy. Without liver transplantation, death from liver failure usually occurs by age five years. Children with the non-progressive hepatic subtype tend to present with hepatomegaly, liver dysfunction, myopathy, and hypotonia; however, they are likely to survive without progression of the liver disease and may not show cardiac, skeletal muscle, or neurologic involvement. The childhood neuromuscular subtype is rare and the course is variable, ranging from onset in the second decade with a mild disease course to a more severe, progressive course resulting in death in the third decade.</Attribute>
                <XRef ID="NBK115333" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23285490</ID>
                <ID Source="BookShelf">NBK115333</ID>
              </Citation>
              <XRef ID="367" DB="Orphanet" />
              <XRef ID="C0017923" DB="MedGen" />
              <XRef ID="MONDO:0009292" DB="MONDO" />
              <XRef Type="MIM" ID="232500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2876759" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000158.4:c.1239delT|Glycogen storage disease type IV" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001461484" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.4:c.1239delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Glycogen storage disease type IV</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4089123" SubmissionDate="2022-02-11" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="8b8408ba-6399-42b9-8f82-0513fc0971fd" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002097101" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The p.Asp413fs variant in GBE1 has been reported in 4 individuals with glycogen storage disease type IV (GSD IV) (PMID: 15019703, 28973083, 22305237, 32746448), segregated with disease in 1 affected relative from 1 family (PMID: 22305237), and has been identified in 0.02% (7/31680) of Latino/Admixed American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs779141550). Although this variant has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. Of the 3 affected individuals, 1 affected individual was a homozygote, and 1 was a compound heterozygote that carried a reported likely pathogenic variant in trans, which increases the likelihood that the p.Asp413fs variant is pathogenic (VariationID: 449406; PMID: 15019703, 28973083). This variant has also been reported in ClinVar (Variation ID#: 449407) and has been interpreted as pathogenic by Invitae, GeneDx, Natera, Inc., and PerkinElmer Genomics. This variant is predicted to cause a frameshift, which alters the proteinâ€™s amino acid sequence beginning at position 413 and leads to a premature termination codon 23 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the GBE1 gene is an established disease mechanism in autosomal recessive GSD IV. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive GSD IV. ACMG/AMP Criteria applied: PVS1, PM3 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000158.4(GBE1):c.1239del</Name>
            <Name>p.Asp413fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.12:g.81586188del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009292" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11072064</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1203948" SubmissionDate="2022-10-12" DateLastUpdated="2023-03-04" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:243393" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617540" DateUpdated="2023-03-04" DateCreated="2017-12-19" Type="SCV" Version="5" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 15019703, 22305237, 20058079, 28973083, 32746448, 27535533)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:700038</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.3:c.1239del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_134_20221012054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_68_20211103121700</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3966532" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="d508e447b4e11e6f2d92039e833eae4b152d729bc311d0e6bd380f6087105c1b|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024208" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.4:c.1239del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2378370" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="4844827|MedGen:C0017923;C1856301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001213011" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15452297</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20058079</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15019703</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28973083</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp413Glufs*23) in the GBE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GBE1 are known to be pathogenic (PMID: 15452297, 20058079). This variant is present in population databases (rs758504480, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with glycogen storage disease type IV (PMID: 15019703, 28973083). ClinVar contains an entry for this variant (Variation ID: 449407). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GBE1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.81635339del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017923" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7844119" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000158.4:c.1239del|OMIM:232500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004198661" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000158.4:c.1239del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="232500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3966532" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2378370" TraitType="Disease" MappingType="XRef" MappingValue="C0017923" MappingRef="MedGen">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2876759" TraitType="Disease" MappingType="Name" MappingValue="Glycogen storage disease type IV" MappingRef="Preferred">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2378370" TraitType="Disease" MappingType="XRef" MappingValue="C1856301" MappingRef="MedGen">
        <MedGen CUI="C1856301" Name="Glycogen storage disease IV, classic hepatic" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4089123" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009292" MappingRef="MONDO">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1203948" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7844119" TraitType="Disease" MappingType="XRef" MappingValue="232500" MappingRef="OMIM">
        <MedGen CUI="C0017923" Name="Glycogen storage disease, type IV" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-06-21">SCV001530158</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

